Table 1. Patient features.
N=661 | Cases (n=186) | Controls (n=475) | p |
Age | 64.80 (SD 16.21) | 49.75 (SD 19.22) | <0.01 |
Males | 91 (49%) | 186 (39%) | 0.02 |
Mild COVID-19 | 21 (11.3%) | 31 (6.5%) | 0.04 |
Obesity | 7 (3.7%) | 11 (2.3%) | 0.6 |
Smoking status | 38 (20.4%) | 55 (11.6%) | <0.01 |
Pregnancy | 0 | 3 (0.6%) | 0.3 |
All-cause hospitalization in the previous three months | 72 (38.7%) | 62 (13%) | <0.01 |
Major surgery in the previous three months | 29 (15%) | 14 (2.9%) | <0.01 |
History of VTE | 20 (10.7%) | 20 (4.2%) | <0.01 |
Known thrombophilia | 3 (1.9%) | 2 (0.4%) | 0.1 |
Active cancer | 57 (30.6%) | 53 (11.1%) | <0.01 |
Polytrauma in the previous three months | 5 (2.7%) | 5 (1%) | 0.1 |
Hormone therapy | 5 (2.7%) | 6 (1.3%) | 0.2 |